Revolution in Neutralizing the Effects of Radiation Exposure

Radiation sickness develops with prolonged exposure to radiation. Until recently, the main problem was that it was impossible to cure it – doctors could only prescribe supportive therapy aimed at preventing complications. But now everything has changed thanks to the development of the drug PLX-R18.

The Essence of the Problem

Radiation exposure can alter the DNA of cells, leading to their death (apoptosis). The bone marrow is primarily affected by ionizing radiation, resulting in impaired production of new blood cells. Consequently, there is a deficiency of red blood cells (leading to anemia), platelets (which can result in bleeding), and white blood cells (which leads to infectious complications). This is why the mortality rate from radiation sickness is high.

Among the severe consequences of radiation exposure are dysfunctions in the digestive system, damage to mucous membranes and skin, and disturbances in the central nervous system, which can result in swelling and hemorrhages in the brain.

Innovative Solution

The drug PLX-R18, developed by Israeli scientists, has successfully passed animal trials. It is still too early to speak about its effectiveness in humans, as research involving radiation exposure to humans is prohibited in Israel. However, the data obtained during the experiments is very promising. The use of PLX-R18 in animals led to a significant reduction in mortality rates.

This revolutionary drug is made from cells harvested from the human placenta. Its active ingredient addresses the main problem that arises from radiation exposure – the disruption of hematopoietic function. PLX-R18 is administered intramuscularly within 4 days after radiation exposure and supports normal bone marrow function. This preserves the production of new blood cells.

Promising Prospects

The Israeli Ministry of Health is in dialogue with representatives of Pluristem to obtain permission to use the drug PLX-R18 in military medical units.

It is quite possible that over time and with additional research, the use of nuclear weapons and technological disasters will not seem as daunting.